The delay for Stealth Biotherapeutics comes amid a heightened focus on the impact FDA job cuts might have on drug reviews.

At Children’s Hospital of Philadelphia, an 11-year-old girl with severe beta thalassamia, became the first pediatric patient to receive Zyntelgo, the first FDA-approved gene therapy for ...

Inspectors found ICU Medical made multiple changes to infusion pumps without submitting premarket notifications.

A federal appeals court has paused a judge’s order to bring a Turkish Tufts University student from a Louisiana immigration ...

Abeona Therapeutics received FDA approval for its cell therapy to treat “butterfly skin,” a rare genetic disease that causes ...

Monogram Technologies (NASDAQ: MGRM) is an AI-driven robotics company focused on improving human health, with an initial focus on orthopedic surgery. The Company is developing a product solution ...

Disparities in prescribing semaglutide and tirzepatide for obesity reveal social factors affecting access and highlight the ...

The Food and Drug Administration is phasing out the use of petroleum-based synthetic dyes by the end of 2026 - a change that ...

After a Consumer Reports study found toxic chemicals in baby formulas, Sen. Jon Ossoff is pressing Abbott Nutrition and Mead Johnson for answers.

Today’s raw milk evangelists like Kennedy claim that it has more nutrients, benefits the immune system, and that kids are ...

Novo Nordisk is collaborating with multiple telehealth organizations in an effort to increase patient access to authentic Wegovy ® (semaglutide). The Company is working with Hims ...

The FDA is recalling bread that was found to have glass fragments on top of the rolls. Three kinds of bread from Upper Crust ...